These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 20659627)

  • 1. "Malignant" intradialytic hypertension: a severe form of intradialytic hypertension.
    Fourtounas C
    Am J Kidney Dis; 2010 Aug; 56(2):418; author reply 418-9. PubMed ID: 20659627
    [No Abstract]   [Full Text] [Related]  

  • 2. [2 cases of malignant arterial hypertension in hemodialysed children, treated with hemofiltration].
    Fischbach M; Schohn D; Jahn H; Geisert J
    Ann Pediatr (Paris); 1982 Nov; 29(9):666. PubMed ID: 7181414
    [No Abstract]   [Full Text] [Related]  

  • 3. Malignant hypertension in a haemodialysis patient treated by ultrafiltration.
    Ok E; Akcicek F; Dorhout Mees EJ; Basci A; Mir S; Kursat S; Unsal A
    Nephrol Dial Transplant; 1995 Nov; 10(11):2124-5. PubMed ID: 8643182
    [No Abstract]   [Full Text] [Related]  

  • 4. Malignant hypertension. Current modes of therapy.
    Dranov J; Skyler JS; Gunnells JC
    Arch Intern Med; 1974 May; 133(5):791-801. PubMed ID: 4595400
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical picture and therapy of malignant hypertension].
    Schoeppe W; Brecht HM; Koch KM
    Med Welt; 1975 Mar; 26(10):417-21. PubMed ID: 1123984
    [No Abstract]   [Full Text] [Related]  

  • 6. Experience with hemodialysis and renal transplantation in patients with malignant hypertension.
    Acchiardo SR; Black WD; Britt L; McKeown JW; Johnson JG; Hatch F
    Proc Clin Dial Transplant Forum; 1974; (4):70-3. PubMed ID: 4619667
    [No Abstract]   [Full Text] [Related]  

  • 7. Hemodialysis-induced hypotension: impact of technologic advances.
    Donauer J
    Semin Dial; 2004; 17(5):333-5. PubMed ID: 15461736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Role of certain factors in prognosis of the course of malignant hypertension in terminal stage of chronic renal insufficiency and the problems of therapeutic tactics].
    Shraer TI; Torgunakov AP; Gorbunov VV; Osipov LE
    Urol Nefrol (Mosk); 1976; (2):18-22. PubMed ID: 982716
    [No Abstract]   [Full Text] [Related]  

  • 9. [Malignant hypertension].
    van Ypersele de Strihou C; Loute G
    Rev Med Suisse Romande; 1974 Nov; 94(11):903-7. PubMed ID: 4155113
    [No Abstract]   [Full Text] [Related]  

  • 10. Mechanism and treatment of malignant hypertension.
    Pérez-Grovas H; Herrera-Acosta J
    Semin Nephrol; 1988 Jun; 8(2):147-54. PubMed ID: 3293138
    [No Abstract]   [Full Text] [Related]  

  • 11. [Development of malignant hypertension as a result of negative sodium balance (author's transl)].
    Haruyama T; Shitomi K; Kaneda H; Takeuchi M; Murata T
    Nihon Jinzo Gakkai Shi; 1977 Jun; 19(6):441-53. PubMed ID: 926435
    [No Abstract]   [Full Text] [Related]  

  • 12. Reversal of excessive hypertension in patients with terminal renal failure by intermittent hemodialysis and bilateral nephrectomy.
    Keynan A; Aviram A; Czaczkes JW; Ullmann TD
    Isr J Med Sci; 1969; 5(3):400-6. PubMed ID: 5821825
    [No Abstract]   [Full Text] [Related]  

  • 13. [Malignant arterial hypertension--clinical picture, prognosis, management].
    Makowiecka-Cieśla M
    Przegl Lek; 1994; 51(1):29-35. PubMed ID: 8208993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Return of renal function after commencing maintenance hemodialysis.
    Maxey RW; Rao TK; Manis T; Delano BG; Friedman EA
    Proc Clin Dial Transplant Forum; 1975 Nov; 5():12-5. PubMed ID: 1232623
    [No Abstract]   [Full Text] [Related]  

  • 15. [Malignant hypertension].
    Ueno Y; Wanaka Y
    Nihon Rinsho; 1992 May; 50 Suppl():459-65. PubMed ID: 1512984
    [No Abstract]   [Full Text] [Related]  

  • 16. Malignant hypertension.
    Reubi E
    Clin Nephrol; 1974; 2(6):211-4. PubMed ID: 4155658
    [No Abstract]   [Full Text] [Related]  

  • 17. Reversible acute renal faiure in diffuse scleroderma.
    Ponticelli C; Ambroso G; Graziani G; Rossi E
    Clin Nephrol; 1980 Jun; 13(6):293-5. PubMed ID: 7408249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sodium profiling, but not cool dialysate, increases the absolute plasma refill rate during hemodialysis.
    Brummelhuis WJ; van Geest RJ; van Schelven LJ; Boer WH
    ASAIO J; 2009; 55(6):575-80. PubMed ID: 19812475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control of hypertension with acute renal failure in scleroderma without nephrectomy.
    Moorthy AV; Wu MJ; Beirne GJ; Sundstrom WS
    Lancet; 1978 Mar; 1(8063):563-4. PubMed ID: 76112
    [No Abstract]   [Full Text] [Related]  

  • 20. [Letter: Hemodialysis in malignant hypertension].
    Orth H; Ritz E
    Dtsch Med Wochenschr; 1975 Mar; 100(13):708. PubMed ID: 1122820
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.